265 related articles for article (PubMed ID: 28258737)
1. Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Jensen EA; Dysart KC; Gantz MG; Carper B; Higgins RD; Keszler M; Laughon MM; Poindexter BB; Stoll BJ; Walsh MC; Schmidt B;
J Pediatr; 2017 Jul; 186():34-40.e2. PubMed ID: 28258737
[TBL] [Abstract][Full Text] [Related]
2. Association between prophylactic indomethacin and death or bronchopulmonary dysplasia: A systematic review and meta-analysis of observational studies.
Jensen EA; Foglia EE; Schmidt B
Semin Perinatol; 2018 Jun; 42(4):228-234. PubMed ID: 29907397
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
Liebowitz M; Clyman RI
J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
[TBL] [Abstract][Full Text] [Related]
4. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.
Slaughter JL; Reagan PB; Newman TB; Klebanoff MA
JAMA Pediatr; 2017 Mar; 171(3):e164354. PubMed ID: 28046188
[TBL] [Abstract][Full Text] [Related]
6. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.
Schmidt B; Asztalos EV; Roberts RS; Robertson CM; Sauve RS; Whitfield MF;
JAMA; 2003 Mar; 289(9):1124-9. PubMed ID: 12622582
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).
Schmidt B; Roberts RS; Fanaroff A; Davis P; Kirpalani HM; Nwaesei C; Vincer M;
J Pediatr; 2006 Jun; 148(6):730-734. PubMed ID: 16769377
[TBL] [Abstract][Full Text] [Related]
8. Outcomes following indomethacin prophylaxis in extremely preterm infants in an all-referral NICU.
Nelin TD; Pena E; Giacomazzi T; Lee S; Logan JW; Moallem M; Bapat R; Shepherd EG; Nelin LD
J Perinatol; 2017 Aug; 37(8):932-937. PubMed ID: 28617424
[TBL] [Abstract][Full Text] [Related]
9. Model for severe intracranial hemorrhage and role of early indomethacin in extreme preterm infants.
Chawla S; Natarajan G; Laptook AR; Chowdhury D; Bell EF; Ambalavanan N; Carlo WA; Gantz M; Das A; Tapia JL; Harmon HM; Shankaran S;
Pediatr Res; 2022 Dec; 92(6):1648-1656. PubMed ID: 35301420
[TBL] [Abstract][Full Text] [Related]
10. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Interventions in Neonatology: How Do They Fare in Real Life?
Rolnitsky A; Lee SK; Piedbouf B; Harrison A; Shah PS;
Am J Perinatol; 2015 Oct; 32(12):1098-104. PubMed ID: 26171598
[TBL] [Abstract][Full Text] [Related]
12. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
13. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
Bassler D; Plavka R; Shinwell ES; Hallman M; Jarreau PH; Carnielli V; Van den Anker JN; Meisner C; Engel C; Schwab M; Halliday HL; Poets CF;
N Engl J Med; 2015 Oct; 373(16):1497-506. PubMed ID: 26465983
[TBL] [Abstract][Full Text] [Related]
14. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
[TBL] [Abstract][Full Text] [Related]
15. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
Potsiurko S; Dobryanskyy D; Sekretar L
BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
[TBL] [Abstract][Full Text] [Related]
16. Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia.
Botet F; Figueras-Aloy J; Miracle-Echegoyen X; Rodríguez-Miguélez JM; Salvia-Roiges MD; Carbonell-Estrany X
BMC Pediatr; 2012 Jun; 12():63. PubMed ID: 22682000
[TBL] [Abstract][Full Text] [Related]
17. Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes.
Edstedt Bonamy AK; Gudmundsdottir A; Maier RF; Toome L; Zeitlin J; Bonet M; Fenton A; Hasselager AB; van Heijst A; Gortner L; Milligan D; Van Reempts P; Boyle EM; Norman M;
Neonatology; 2017; 111(4):367-375. PubMed ID: 28125815
[TBL] [Abstract][Full Text] [Related]
18. Decrease in incidence of bronchopulmonary dysplasia with erythropoietin administration in preterm infants: a retrospective study.
Rayjada N; Barton L; Chan LS; Plasencia S; Biniwale M; Bui KC
Neonatology; 2012; 102(4):287-92. PubMed ID: 22922736
[TBL] [Abstract][Full Text] [Related]
19. Trends in Bronchopulmonary Dysplasia Among Extremely Preterm Infants in Japan, 2003-2016.
Nakashima T; Inoue H; Sakemi Y; Ochiai M; Yamashita H; Ohga S;
J Pediatr; 2021 Mar; 230():119-125.e7. PubMed ID: 33246013
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic closure of the ductus arteriosus: benefits and limitations.
Mercanti I; Boubred F; Simeoni U
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
